Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Sovateltide by Pharmazz for Hypoxic-Ischemic Encephalopathy: Likelihood of Approval
Sovateltide is under clinical development by Pharmazz and currently in Phase I for Hypoxic-Ischemic Encephalopathy. According to GlobalData, Phase I...